Karen Kingston annihilates the Pfizer clinical trial and removes Pfizers legal liability shield

Karen Kingston has produced a seminal analysis of the Pfizer clinical trials that removes any liability shield attaching to Pfizer.

From here:

Early Data Proves Pfizer Vaccines Don’t Prevent Transmission Needs Context (substack.com)

https://karenkingston.substack.com/p/early-data-proves-pfizer-vaccines

Brilliant work from Karen Kingston. I urge you to read the entire piece.

I have been anchoring on a 51 page analysis of the Pfizer Phase 3 clinical trial by the Canadian Covid Care Alliance here:

The COVID-19 Inoculations - More Harm Than Good FINAL Video & Print (canadiancovidcarealliance.org)

https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf

Karen Kingston’s analysis goes into even greater depth and includes all the source documents submitted by Pfizer to the FDA.

Here are my key takeaways from her analysis in the form of selected extracts from the article:

1. “The November 20, 2020 EUA PFIZER/BioNTech data submitted to the FDA irrefutably proves there is NO EVIDENCE that PFIZER mRNA vaccines prevent transmission. The data also proves that the PFIZER mRNA vaccines cause COVID-19.”

2. “PFIZER’s November 20, 2020, EUA data isn’t even EUA data. The November 20th data is interim IND Phase 3 data submitted under an EUA. PFIZER’s phase 1/2/3 trials (filed under an IND) are not and never were protected under the EUA laws, despite what we’ve been told.”

3. “PFIZER and the FDA had evidence before PFIZER submitted phase 3 data, that that the mRNA COVID-19 vaccines caused disease, disabilities and death in adults and children.”

4. It is evident that PFIZER and the FDA are in criminal violation of dozens of laws under the FDA&C Act. You can read some select violations of those laws here.

5. “…the incidence of COVID-19 generally increased in each group of study participants with increasing time post-Dose 2.” - PFIZER”

6. The adverse events of the COVID-19 mRNA vaccines are the same as the symptoms of COVID-19; resulting in disabilities, disease, and death.

That last point links with another I have been thinking about. How does a C19/SARS-COV2 test distinguish between spike proteins from a C19/SARS-COV2 infection and a C19 injection?

My other articles, citing the BMJ, state the primary end-points of the clinical trial here:

Pfizer fraudulently misrepresented the end points in its clinical trial (substack.com)

https://peterhalligan.substack.com/p/pfizer-fraudulently-misrepresented

Karen Kingston has a nuanced and slightly different take.

“The primary efficacy endpoint was the incidence of SARS-CoV-2 infection in patients 1- week after their 2nd dose of PFIZER (or placebo), confirmed by reporting of COVID-19 symptoms AND a positive PCR-test.”

“According to the CDC (and the MAYO Clinic), patients are not ‘fully vaccinated’ until 2-weeks after their second dose of an mRNA COVID-19 vaccine, including PFIZER’s vaccine. Yet, the primary efficacy endpoint in the PFIZER study was a positive PCR test at 1-week post 2nd dose.”

Quite the logic error! End point incidence = infection one week after 2nd dose which does not take effect for two weeks!

“..data that proves the PFIZER vaccines cause COVID-19. On page 41 of PFIZER’s EUA submission, states that there were 409 patients who had COVID-19 symptoms within 7 days of getting their first or second PFIZER shot, but these patients did not have a positive PCR-test for SARS-CoV-2..” “..Per PFIZER’s own document, “unconfirmed COVID-19 cases could have masked clinically significant adverse events that would have otherwise been detected.”

409 patients with unconfirmed C19 symptoms within a week of first ot second dose that could have been suffering from undetected but SIGNIFICANT adverse events .. hmm - what kind of patient monitoring wss there that wasn’t looking for SIGNIFICANT adverse events?

Karen Kingston states this:

“Per page 18, Table 2, of the November 20, 2020, submission, 622 PFIZER subjects were excluded (withdraw) for protocol deviations (vs 121 who were excluded/withdrew from the placebo group).

What were the reasons for the PFIZER subjects exclusion/withdrawal? Were they hospitalized? Did they die?”

That withdrawal of 622 from the injected group is out of a starting number of around 22,500 - the 121 withdrawn from the placebo group of roughly the same size is one fifth that number - which begs the question “were the (5x) withdrawals from the injected group CAUSED by the injections?”

HHS rules state that, under EUA, record keeping for anyone dropping out of a study is up to the manufacturer and not required. Pfizer stated that adverse events, including death, were reasons for withdrawal from the study.

“Per PFIZER’s EUA submission, clinically significant or severe COVID-19 cases was defined in the Phase 3 Study as kidney, liver, or neurological dysfunction*, admission to the intensive care unit, or death.”

So, clinically significant = major organ dysfunction (but not heart dysfunction - and not lung dysfunction for a respiratory infection!) ICU admission or death = significant or severe C19 cases. ICU admission and death were not clinical trial endpoints as stated in the BMJ article referenced above, but nonetheless shocking as an exclusion amongst both the injected group and the placebo group in the Phase 3 clinical trial.

A “most excellent” article from Karen Kingston. I highly recommend reading it..twice or three times!